You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV genotype 1 (GT-1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

DM1 Patients in China

Enrolling by invitation
  • Myotonic Dystrophy 1
  • Brain MRI scan
  • Shanghai, China
    Huashan Hospital
Oct 20, 2023

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

HCV Infection Trial in Hong Kong (SOF+DCV+CDI-31244, SOF+DCV+CDI-31244+ASV)

Withdrawn
  • HCV Infection
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
May 5, 2020

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Low Dose OXIRI (LD-OXIRI)
    • Singapore, Singapore
      National Cancer Centre, Singapore
    Jun 29, 2023

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    Has Results
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Impact of CES1 Genotype on Remimazolam

    Not yet recruiting
    • American Society of Anesthesiologists (ASA) Class 1-2
    • +3 more
    • Remimazolam besylate
    • (no location specified)
    Apr 24, 2023

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

    Completed
    Has Results
    • Hepatitis C Infection
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    UGT1A1 Genotyping in Taiwanese Cancer Patients

    Not yet recruiting
    • The Influence of the UGT1A1 Genotype
      • (no location specified)
      Mar 20, 2023

      Naïve Hepatitis C Virus Genotype 1 Suffering From Fatigue and

      Completed
      Has Results
      • Chronic Hepatitis C Virus (HCV)
        • St. Gallen, Sankt Gallen, Switzerland
        • +4 more
        Sep 30, 2019

        Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

        Recruiting
        • Chronic Hepatitis C
        • Chronic Hepatitis B
        • Tenofovir Alafenamide 25 MG
        • Sofosbuvir / Velpatasvir
        • Beijing, Beijing, China
          Peking University First Hospital
        Aug 2, 2021

        HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))

        Active, not recruiting
        • HIV-1-infection
        • eOD-GT8 60mer mRNA Vaccine (100µg)
        • Kigali, Rwanda
        • +1 more
        Sep 9, 2022

        Alpha -1- Microglobulin asEarly Biomarker in Renal Extrahepatic

        Not yet recruiting
        • Renal Injury
        • HCV
          • (no location specified)
          May 3, 2022

          Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

          Not yet recruiting
          • Crohn Disease
          • Infliximab
          • (no location specified)
          Apr 3, 2023

          Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

          Completed
          • Chronic Hepatitis c Genotype 1
          • Moscow, Russian Federation
          • +4 more
          Oct 27, 2022

          Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

          Completed
          Has Results
          • Hepatitis C Infection
          • HIV Infection
          • Nitazoxanide With Pegylated Interferon And Ribavirin
          • Washington, District of Columbia
          • +3 more
          Sep 14, 2021

          Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

          Completed
          Has Results
          • Hepatitis C Virus Infection
          • +3 more
          • ABT-493 coformulated with ABT-530
          • (no location specified)
          Jul 9, 2021